Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer
Lung cancer is a leading cause of cancer death, where the amplification of oncogenes contributes to tumorigenesis. Genomic profiling of 128 lung cancer cell lines and tumors revealed frequent focal DNA amplification at cytoband 14q13.3, a locus not amplified in other tumor types. The smallest region...
Saved in:
Published in | Oncogene Vol. 27; no. 25; pp. 3635 - 3640 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
05.06.2008
Nature Publishing Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Lung cancer is a leading cause of cancer death, where the amplification of oncogenes contributes to tumorigenesis. Genomic profiling of 128 lung cancer cell lines and tumors revealed frequent focal DNA amplification at cytoband 14q13.3, a locus not amplified in other tumor types. The smallest region of recurrent amplification spanned the homeobox transcription factor
TITF1
(thyroid transcription factor 1; also called
NKX2-1
), previously linked to normal lung development and function. When amplified,
TITF1
exhibited increased expression at both the RNA and protein levels. Small interfering RNA (siRNA)-mediated knockdown of TITF1 in lung cancer cell lines with amplification led to reduced cell proliferation, manifested by both decreased cell-cycle progression and increased apoptosis. Our findings indicate that
TITF1
amplification and overexpression contribute to lung cancer cell proliferation rates and survival and implicate
TITF1
as a lineage-specific oncogene in lung cancer. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/sj.onc.1211012 |